Increase in the therapeutic effect of doxorubicin induced by monoclonal antibodies raised against this drug.
Villa
E
E
Division of Experimental Oncology E, Istituto Nazionale dei Tumori, Milan, Italy.
Balsari
A
A
Sardini
A
A
Morelli
D
D
Ménard
S
S
Colnaghi
M I
MI
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D004317:Doxorubicin / Q000276:immunology / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007941:Leukemia P388 / Q000188:drug therapy; D051379:Mice; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D004317:Doxorubicin